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J Vet Diagn Invest 15:320–323 (2003)
Abundant PrPCWD in tonsil from mule deer with preclinical
chronic wasting disease
Katherine I. O’Rourke, Dongyue Zhuang, Amy Lyda, Gabriel Gomez, Elizabeth S. Williams,
Wenbin Tuo, Michael W. Miller
Abstract. A monoclonal antibody dot-blot assay was used to evaluate detergent lysates of tonsil tissue from
mule deer to detect PrPCWD, the marker for the cervid transmissible spongiform encephalopathy chronic wasting
disease (CWD). Samples of formalin-fixed brain and tonsil tissues from mule deer were examined for PrPCWD
using immunohistochemistry (IHC) with Mab F99/97.6.1, the gold standard for diagnosis of preclinical CWD.
The contralateral tonsil from each of the 143 deer was prepared for confirmatory IHC and as a 10% (wt/vol)
detergent lysate without purification or enrichment steps for monoclonal antibody dot-blot assay. PrPCWD was
detected by dot-blot assay in 49 of 50 samples considered positive by IHC. Forty-eight of the positive samples
were evaluated with a quantitative dot-blot assay calibrated with recombinant PrP. Tonsillar PrPCWD concentra-
tions ranged from 34 to 1,188 ng per 0.5 mg starting wet weight of tissue. The abundant PrPCWD in mule deer
tonsil will facilitate development and validation of high-throughput screening tests for CWD in large populations
of free-ranging deer.
Chronic wasting disease (CWD) of mule deer (Odo-
coileus hemionus) is a transmissible spongiform en-
cephalopathy11 characterized by accumulation of
PrPCWD, the disease-associated isoform of the host pri-
on protein formed by posttranslational changes affect-
ing secondary structure, solubility, and relative resis-
tance to proteases. Chronic wasting disease is diag-
nosed by the detection of PrPCWD in the central nervous
system by immunohistochemistry (IHC) assay of the
medulla at the level of the obex.3 PrPCWD accumulates
in the lymphoid tissues of infected deer well before
the central nervous system is involved.8,10 Tonsil or
lymph node testing is therefore a useful adjunct to IHC
when testing deer with preclinical disease, increasing
the sensitivity of surveillance testing by approximately
10%.4 Lymphoid PrPCWD is detectable by monoclonal
antibody IHC,9 but this assay is relatively expensive
and time-consuming. Higher-throughput tests devel-
oped for bovine spongiform encephalopathy have been
described.1,2,7 These assays are based on the detection
of the disease-associated isoform of PrP in detergent
lysates of the brain, the tissue with the highest accu-
mulation of the abnormal protein. Adaptation of high-
throughput tests for early detection of CWD in clini-
cally normal deer in large-scale CWD surveillance
programs would be feasible if PrPCWD were abundant
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in lymphoid tissues from infected animals. In this
study, a semiquantitative assay was used to determine
whether PrPCWD could be detected in crude detergent
lysates of tonsil from preclinically infected mule deer.
Materials and methods
Tissue collection. Brain (including medulla oblongata at
the level of the obex) and both palatine tonsils were col-
lected from mule deer within and outside a well-defined en-
demic area in Colorado. All deer were hunter harvested and
not reported as clinical suspects. However, the early signs
of CWD may be subtle, and hunter reports may be unreli-
able. Medulla and 1 tonsil were fixed in formalin. Histologic
evaluation was performed on medulla samples. Medulla and
tonsil were examined by a standardized automated IHC as-
say.4,9 Tonsils from mule deer at various stages of disease4
were examined. These included deer with spongiform en-
cephalopathy in the medulla and PrPCWD in the medulla and
tonsil (n 5 15), PrPCWD in the tonsil and the dorsal motor
nucleus of the vagus nerve but with no spongiform change
(n 5 2), and PrPCWD detected in tonsil but not in brain (n 5
2). An additional 31 samples from clinically normal hunter-
harvested mule deer, which were considered positive by IHC
assay of the tonsil, were also tested. Negative control sam-
ples (n 5 114) were collected from deer outside the endemic
area; neither spongiform change nor PrPCWD in medulla or
tonsil was found in these samples. For these 164 (50 positive
and 114 negative) samples, the second tonsil was chilled and
cut into 3 pieces; the center section was fixed in formalin
for confirmatory IHC, and the 2 outer sections were held at
220 C for dot-blot assay.
Tissue preparation. Dot-blot analysis was performed us-
ing 150 mg of frozen deer tonsil tissue. The tissue was finely
minced with scissors and mixed with 900 ml of lysis buffer
(0.5% nonylphenol ethoxylate (NP-40), 0.5% sodium deoxy-
cholate, 10 mM Tris–HCl, pH 7.5). The sample was incu-
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Figure 1. Dot-blot analysis of crude tonsil homogenates from deer with CWD—row 2, columns A–G and row 3, columns A–C,
negative control deer (row 1, columns A and B). Calibration standards (rows 5 and 6) are serial 2-fold dilutions of recombinant ovine PrP
ranging from 240 ng (column A) to 3.25 ng (column G).
bated at room temperature (RT) for 2 hr and then centrifuged
at 1,000 3 g for 5 min. Supernatants were held at 220 or
280 C. Immediately before use, 20-ml aliquots of superna-
tant from each prepared sample were incubated with pro-
teinase K (PK1) or without PK (PK2) (final concentration
100 mg/ml) at 50 C for 40 min. The samples were mixed
with an equal volume of 23 dot-blot sample buffer (125 mM
Tris–HCl, pH 6.8, 6 mM ethylenediamine tetraacetic acid, 8
M urea, and 8% 2-mercaptoethanol) and boiled for 5 min.
Dot-blot assay. Polyvinylidene difluoride membranes
were pretreated with methanol for 15 sec and soaked in dis-
tilled water for 5 min. After the membrane was completely
dried, 6-ml aliquots of prepared tonsil sample (duplicate al-
iquots of PK1 and PK2 samples) were applied to the mem-
brane in a 0.8-cm grid and allowed to dry for 2–18 hr at RT.
The membrane was blocked with 1% casein adjusted to
0.05% Tween-20 (blocking buffer) (20 ml per 7- 3 8-cm
membrane) at RT for 1 hr, incubated with 10 ml of primary
antibody (F99/97.6.1a 3.5 mg/ml in blocking buffer) at RT
for 1 hr with constant agitation, and then washed 3 times, 5
min each, with 0.01 M Tris–HCl, pH 8.0, 0.15 M NaCl, and
0.05% Tween 20 (wash buffer). The membrane was incu-
bated with 10 ml of secondary antibody (1:5,000 dilution in
blocking buffer goat anti-mouse IgG1 conjugated with horse-
radish peroxidaseb) at RT for 30 min with constant agitation
and washed 5 times, 5 min each, with wash buffer. The
membrane was developed for enhanced chemiluminescencec
and exposed to film. The density of the signal for each dot
was determined by a digital imaging system.d
PrPCWD quantitation. Adequate tissue was available for
quantitation from 48 PrPCWD-positive samples. Samples were
assayed as described above on filters loaded with calibration
standards prepared from recombinant ovine PrP6 that shares
the conserved epitope (QYQRES) for Mab F99/97.6.15 with
cervid PrP. Serial 2-fold dilutions of the recombinant PrP
were prepared in lysis, denaturation, and dot-blot sample
buffers as described above without PK digestion. Calibrators
were assayed in duplicate, and the mean density for each
calibrator was plotted against concentration for linear re-
gression analysis. Tonsil samples were assayed twice on in-
dependent runs as described above. The PrPCWD concentra-
tion for each tonsil sample was extrapolated from the stan-
dard curve for each filter, the mean values for replicate runs
were determined, and the results were expressed as nano-
grams of PrPCWD per 0.5 mg starting wet weight of tissue.
Samples with densitometry readings greater than those of
the 240-ng calibration standard were diluted 1:2, 1:5, or 1:
10 before addition of denaturation buffer or dot-blot sample
buffer.
Results
A monoclonal antibody dot-blot assay for detection
of PrPCWD in deer tonsil was used to evaluate the fea-
sibility of assays using crude detergent lysates without
further enrichment or purification steps. Using this as-
say, 164 tonsil samples were studied for detectable
PrPCWD. The mean densitometry reading for the sam-
ples considered true negatives (collected from outside
the reported CWD endemic area) was 45 (range 5 16–
78; SD 5 15). Forty-nine of 50 samples that were
considered CWD positive by IHC had densitometry
readings that were significantly higher (P , 0.01) than
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Figure 2. Mean densitometric readings by immunodot-blot as-
say for calibrators prepared from recombinant ovine PrP. Calibration
standards were prepared in duplicate as serial 2-fold dilutions of
recombinant ovine PrP (recOvPrP) ranging from 3.25 to 240 ng.
the mean of the negative samples (mean reading 5
2,650; range 159–5,468; SD 5 1,267). One sample
considered positive by IHC was negative by dot-blot
densitometry (densitometry reading 5 75) and by
Western blot (data not shown).
Sufficient tonsil tissue from 48 CWD-positive deer
was available for quantitation using the same dot-blot
assay calibrated with serial 2-fold dilutions of a recom-
binant ovine PrP. Representative results are shown in
Fig. 1. Calibrators between 15 and 240 ng were as-
sayed in duplicate. The R2 value for linear regression
of the calibration curve between 30 and 240 ng was
0.9979 (Fig. 2). Tonsil lysates with densitometry read-
ings higher than those of the 240-ng calibration stan-
dard were diluted 1:2, 1:5, or 1:10 before addition of
the lysis, denaturation, and sample buffers. PrPCWD
concentration in each sample was determined by ex-
trapolation from the standard curve and adjusted for
dilution if necessary. PrPCWD concentrations ranged
from 34 to 1,188 ng in 0.5-mg equivalent wet weight
of starting tissue (mean concentration 336 ng; SD 5
229).
Discussion
This study examined the feasibility of using crude
detergent lysates of tonsil tissue for inexpensive dot-
blot diagnostic testing of mule deer for CWD. Using
a quantitative dot-blot assay, PrPCWD levels in mule
deer tonsil exceeded 34 ng/0.5 mg of starting tissue,
readily detectable without enrichment steps. One sam-
ple, considered positive for PrPCWD by IHC, showed
no signal on dot-blot analysis. Discordant results may
be attributed to differences in assay sensitivity or to
differences in tissue processing. Immunohistochemis-
try analysis can detect single PrPCWD-positive cells and
may be a more sensitive test for specimens with oc-
casional single-cell staining. However, PrPCWD immu-
nostaining, when detected, typically involves more
than half the lymphoid follicles in a section.9 In the
case of the false-negative sample in this study, the IHC
assay of the center tissue fixed in formalin showed
clear and abundant staining, although the dot-blot and
Western blot analyses (data not shown) on the flanking
tissue sections were negative. Relative sensitivity of
the dot-blot system was less likely a cause for the dis-
cordant event than improper trimming of the relatively
small tonsil. Likewise, the wide variation in PrPCWD
levels is largely attributed to the regional distribution
of the immunoreactive material in scattered germinal
centers. This effect is even more pronounced in ret-
ropharyngeal nodes, a tissue preferred over the tonsil
for necropsy specimens because of its size and ease of
collection in the field. Standardization of tissue collec-
tion and trimming techniques will be critical to the
accuracy of high-throughput tests. Efficient methods
for tissue dispersion, selection of appropriate indicator
tissues, and conversion to a 96-well plate suitable for
laboratory robotics and a digital readout will be nec-
essary for increasing throughput to meet the anticipat-
ed demands for CWD surveillance testing. However,
the abundant levels of PrPCWD in lymphoid tissues of
mule deer with CWD suggest that high-throughput,
rapid, inexpensive tests for deer-associated CWD are
feasible.
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